Sign up to save your podcasts
Or
Share Episode 5: IDH Inhibitors in AML: not so AGILE
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 5: IDH Inhibitors in AML: not so AGILE
In this episode, Bernie Marini and Anthony Perissinotti chat with special guest Charles Foucar, MD, a hematology specialist and expert in the field. We discuss the controversial FDA approval of ivosidenib in combination with azacitidine in newly diagnosed IDH1+ AML, based on the results of the AGILE study: https://www.nejm.org/doi/full/10.1056/NEJMoa2117344
View all episodes
By Bernard Marini, Anthony Perissinotti, et al.
4.5
3030 ratings
In this episode, Bernie Marini and Anthony Perissinotti chat with special guest Charles Foucar, MD, a hematology specialist and expert in the field. We discuss the controversial FDA approval of ivosidenib in combination with azacitidine in newly diagnosed IDH1+ AML, based on the results of the AGILE study: https://www.nejm.org/doi/full/10.1056/NEJMoa2117344
More shows like WolverHeme Happy Hour
View all
Fresh Air
38,498 Listeners
The NPR Politics Podcast
25,784 Listeners
Pod Save America
87,123 Listeners
The Daily
111,918 Listeners
Up First from NPR
56,500 Listeners
OncoPharm
187 Listeners
Today, Explained
10,212 Listeners
Interesting Times with Ross Douthat
7,222 Listeners
Blood Podcast
52 Listeners
ASTCT Talks
8 Listeners
The Ezra Klein Show
15,794 Listeners
The Weekly Show with Jon Stewart
10,720 Listeners
Blood Cancer Talks
51 Listeners
Two Onc Docs
192 Listeners
The Headlines
614 Listeners